Rebound Following Hemodialysis of Cimetidine and Its Metabolites
- 1 May 1984
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 3 (6) , 430-435
- https://doi.org/10.1016/s0272-6386(84)80006-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function.British Journal of Clinical Pharmacology, 1982
- NEUROLOGICAL DYSFUNCTION ASSOCIATED WITH ABNORMAL LEVELS OF CIMETIDINE METABOLITEThe Lancet, 1981
- Removal of Cimetidine by Peritoneal Dialysis, Hemodialysis, and Charcoal HemoperfusionTherapeutic Drug Monitoring, 1980
- N‐Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysisClinical Pharmacology & Therapeutics, 1979
- Drug Kinetics and Artificial Kidneys1Clinical Pharmacokinetics, 1977
- N‐acetylprocainamide levels in patients with end‐stage renal failureClinical Pharmacology & Therapeutics, 1976
- HEMODIALYSIS FOR LITHIUM POISONINGThe Lancet, 1969